Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

vaccine3a-062568e

Sanofi’s dengue vaccine scores 11th worldwide approval in Singapore

October 4, 2016 Sales and Marketing Sanofi, dengue, drug approval

Sanofi Pasteur, the vaccines unit of the wider French firm, has announced that its dengue vaccine Dengvaxia has secured market …
News
shutterstock_235920349

NICE and the CDF: Are they still up to scratch?

October 4, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer Drugs Fund, NICE

Originally published in the October issue of Pharmafocus, Matt Fellows explores medical and pharmaceutical opinion of the divisive institute to …
Feature
merrimack-pharmaceuticals

Merrimack Pharmaceuticals’ CEO resigns and workforce cut by nearly a quarter

October 3, 2016 Sales and Marketing Gary Crocker, Merrimack Pharmaceuticals, Robert Mulroy

Merrimack Pharmaceuticals announced that they would cut away 22% of their workforce and their CEO, Robert Mulroy, would leave immediately …
News
jj_2johnson_and_johnson

J&J’s IL-23 drug guselkumab outstrips the competition in Phase III trial

October 3, 2016 Research and Development, Sales and Marketing AbbVie, Humira, Johnson & Johnson, guselkumab

Johnson & Johnson’s IL-23 drug guselkumab proved to be more effective at clearing moderate to severe cases of the plaque …
News
eylea-product-box-md

Regeneron’s Eylea fails combination study endpoint

October 3, 2016 Research and Development, Sales and Marketing Eylea, Regeneron

Regeneron has announced that its eye drug Eylea (aflibercept) failed its primary endpoint in a mid-stage trial investigating its effectiveness …
News
novartis_window

Novartis reveals impressive four year data upon Cosentyx

October 3, 2016 Sales and Marketing Cosentyx, Novartis, psoriasis

Novartis announced on October 1 that Cosentyx (secukinumab) had delivered a high percentage and long-lasting skin clearance in patients with …
News
shutterstock_168864905

GSK agrees to $20m settlement for Chinese bribery allegation

October 3, 2016 Business Services, Sales and Marketing China, GSK, GlaxoSmithKline

GlaxoSmithKline has agreed to settle a bribery allegation in China with a payment of $20 million to the US Securities …
News
medimmune

AstraZeneca agrees $250 million licensing agreement with Allergan

October 3, 2016 Sales and Marketing Allergan, AstraZeneca, Crohn’s disease, MEDI2070, MedImmune, crohn's disease

Allergan has entered into a licensing agreement with MedImmune, of AstraZeneca, for the global rights of MedI2070, a synthetic antibody. …
News
david_goldstein

Professor David Goldstein appointed as chief adviser for AstraZeneca’s genomics initiative

September 30, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AstraZeneca today announced that Professor David Goldstein will join the Company in the consultative role of Chief Adviser, Genomics to …
Appointment
oncology_no_border

Pharmafocus: Advances in Oncology available now!

September 30, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, oncology, pharmafocus supplement

The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the …
News
top_ten_stories

Top Ten articles in the Pharma Industry this week

September 30, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Coming towards the end of September, we’ve had some major developments in drug trials and bad news for some of …
News

NICE rejects Lilly lung cancer drug, recommends Bayer’s Xofigo and Amgen’s Imlygic

September 30, 2016 Medical Communications, Sales and Marketing Imlygic, NICE, Portrazza, xofigo

The National Institute of Health and Care Excellence has issued final guidance rejecting Eli Lilly’s Portrazza (necitumumab) for the treatment …
News
brian_mcnamara

GSK appoints Brian McNamara chief of consumer health division

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brian McNamara, Emma Walmsley, GlaxoSmithKline

GlaxoSmithKline PLC has named Brian McNamara the head of its consumer-health division. The new comes a week after the announcement …
Appointment
abbvie-singapore

AbbVie opens its $300 million manufacturing plant in Singapore

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Asia, Singapore

AbbVie’s new Singapore based manufacturing plant is expected to be fully operational by late 2018. The plant is expected to …
News

The October issue of Pharmafocus is now live!

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

The latest edition of Pharmafocus is available online now.
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026